Phase II trial of olaparib in homologous recombination deficient malignant mesothelioma

Gender
Any

Age Group
Any

At a Glance

IRB#IRB20-0117

Lead PhysicianHedy Kindler

Collaborator(s)N/A

EligibilityRecruiting